KIET TUAN TRUONG

Allopathic & Osteopathic Physicians|Family Medicine COPPELL, TX NPI 1801152913

General Payments — all program years on this page

$1,366.52

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 81
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $331.15 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $331.1520

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $109.117
Lilly USA, LLC $60.944
Exact Sciences Corporation $46.703
Astellas Pharma US Inc $41.292
ABBVIE INC. $20.851
Abbott Laboratories $20.211
DEXCOM, INC. $18.391
GlaxoSmithKline, LLC. $13.661

By program year

Program yearAmountRecords
2021 $153.789
2022 $384.6423
2023 $496.9529
2024 $331.1520

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096580063 Novo Nordisk Inc $14.20 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096674095 Novo Nordisk Inc $14.21 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096737796 Novo Nordisk Inc $15.03 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096844863 Novo Nordisk Inc $17.54 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096922498 Novo Nordisk Inc $15.12 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096971237 Novo Nordisk Inc $15.60 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097094283 Novo Nordisk Inc $17.41 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106247251 ABBVIE INC. $20.85 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114935658 Exact Sciences Corporation $15.69 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114935663 Exact Sciences Corporation $15.69 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114935667 Exact Sciences Corporation $15.32 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116270582 GlaxoSmithKline, LLC. $13.66 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125278828 Abbott Laboratories $20.21 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135112466 Lilly USA, LLC $15.38 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135112468 Lilly USA, LLC $14.42 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135122887 Lilly USA, LLC $16.54 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135134510 Lilly USA, LLC $14.60 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139267564 Astellas Pharma US Inc $20.04 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139323678 Astellas Pharma US Inc $21.25 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153314514 Dexcom, Inc. $18.39 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.